Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Reply: Clinical trial registry alone is not adequate: on the perception of possible endpoint switching and P-hacking.
Abbara A, Clarke S, Islam R, Prague JK, Comninos A, Narayanaswamy S, Papadopoulou DA, Roberts RE, Izzi-Engbeaya CN, Ratnasabapathy R, Nesbitt A, Vimalesvaran S, Salim R, Lavery SA, Bloom SR, Huson L, Trew GH, Dhillo WS. Abbara A, et al. Among authors: lavery sa. Hum Reprod. 2018 Feb 1;33(2):342-344. doi: 10.1093/humrep/dex360. Hum Reprod. 2018. PMID: 29194495 Free article. No abstract available.
A second dose of kisspeptin-54 improves oocyte maturation in women at high risk of ovarian hyperstimulation syndrome: a Phase 2 randomized controlled trial.
Abbara A, Clarke S, Islam R, Prague JK, Comninos AN, Narayanaswamy S, Papadopoulou D, Roberts R, Izzi-Engbeaya C, Ratnasabapathy R, Nesbitt A, Vimalesvaran S, Salim R, Lavery SA, Bloom SR, Huson L, Trew GH, Dhillo WS. Abbara A, et al. Among authors: lavery sa. Hum Reprod. 2017 Sep 1;32(9):1915-1924. doi: 10.1093/humrep/dex253. Hum Reprod. 2017. PMID: 28854728 Free PMC article. Clinical Trial.
The direct and indirect effects of kisspeptin-54 on granulosa lutein cell function.
Owens LA, Abbara A, Lerner A, O'floinn S, Christopoulos G, Khanjani S, Islam R, Hardy K, Hanyaloglu AC, Lavery SA, Dhillo WS, Franks S. Owens LA, et al. Among authors: lavery sa. Hum Reprod. 2018 Feb 1;33(2):292-302. doi: 10.1093/humrep/dex357. Hum Reprod. 2018. PMID: 29206944 Free article. Clinical Trial.
Efficacy of Kisspeptin-54 to Trigger Oocyte Maturation in Women at High Risk of Ovarian Hyperstimulation Syndrome (OHSS) During In Vitro Fertilization (IVF) Therapy.
Abbara A, Jayasena CN, Christopoulos G, Narayanaswamy S, Izzi-Engbeaya C, Nijher GM, Comninos AN, Peters D, Buckley A, Ratnasabapathy R, Prague JK, Salim R, Lavery SA, Bloom SR, Szigeti M, Ashby DA, Trew GH, Dhillo WS. Abbara A, et al. Among authors: lavery sa. J Clin Endocrinol Metab. 2015 Sep;100(9):3322-31. doi: 10.1210/jc.2015-2332. Epub 2015 Jul 20. J Clin Endocrinol Metab. 2015. PMID: 26192876 Free PMC article. Clinical Trial.
Congenital uterine anomalies and their impact on fertility.
Hassan MA, Lavery SA, Trew GH. Hassan MA, et al. Among authors: lavery sa. Womens Health (Lond). 2010 May;6(3):443-61. doi: 10.2217/whe.10.19. Womens Health (Lond). 2010. PMID: 20426609 Free article. Review.
FSH Requirements for Follicle Growth During Controlled Ovarian Stimulation.
Abbara A, Patel A, Hunjan T, Clarke SA, Chia G, Eng PC, Phylactou M, Comninos AN, Lavery S, Trew GH, Salim R, Rai RS, Kelsey TW, Dhillo WS. Abbara A, et al. Among authors: lavery s. Front Endocrinol (Lausanne). 2019 Aug 27;10:579. doi: 10.3389/fendo.2019.00579. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31507532 Free PMC article.
Clinical parameters of ovarian hyperstimulation syndrome following different hormonal triggers of oocyte maturation in IVF treatment.
Abbara A, Islam R, Clarke SA, Jeffers L, Christopoulos G, Comninos AN, Salim R, Lavery SA, Vuong TNL, Humaidan P, Kelsey TW, Trew GH, Dhillo WS. Abbara A, et al. Among authors: lavery sa. Clin Endocrinol (Oxf). 2018 Jun;88(6):920-927. doi: 10.1111/cen.13569. Epub 2018 Mar 6. Clin Endocrinol (Oxf). 2018. PMID: 29446481 Free PMC article.
74 results